Coastal Vision Medical Group, leading ophthalmology practice, is among the first in Southern California to offer EVO Visian ICL to provide visual freedom from glasses and contact lenses.
FREMONT, CA: Almost all complications result from poor hygiene and maintenance, but the fact remains that contact lenses pose a greater risk than glasses. Irritation, conjunctivitis, dry eye syndrome, and other unpleasant eye problems can result from poor lens care.
EVO Visian® ICL is a clinically validated, evolutionary implantable lens that corrects common vision abnormalities such as nearsightedness and nearsightedness with astigmatism. While more than one million EVO lenses have been implanted worldwide, the EVO Visian ICL is now FDA approved in the United States and can provide a new option for those seeking sharp, clear vision without the hassles of contact lenses or eyeglasses. Coastal Vision Medical Group is now offering EVO, making it one of the first ophthalmology practices in Orange County, LA County, and the Inland Empire to offer this groundbreaking vision correction technique.
The EVO Visian ICL lens is slightly smaller than a standard contact lens and is implanted in the eye between the natural lens and the iris (colored part of the eye) for vision improvement. The EVO lens differs from other ophthalmologist-performed vision correction options, such as LASIK, in that it is additive; that is, it is implanted in the eye and does not require the removal of corneal tissue. The EVO lens is designed to work in tandem with the natural eye, providing sharp, clear vision, excellent night vision, and UV protection. Furthermore, the EVO lens does not cause dry eyes. While the EVO Visian ICL lens is the latest in the US market, over 1,000,000 EVO ICL lenses have been implanted in Asia, Europe, and other parts of the world.
"The EVO procedure was life changing for me," said Orange County Optometrist and Coastal Vision Patient Dr. Kathryn Pham. "I struggled with wearing contact lenses and glasses for most of my life and was not a good candidate for LASIK. The ICL procedure was quick and I could see clearly right away. I would recommend this procedure for anyone who wants to ditch glasses or contacts."
Myopia (or nearsightedness) is the most common ocular disorder globally, and its prevalence is rapidly increasing. Myopia affects an estimated 30 percent of the world's population or 2.6 billion people, and this figure is expected to rise to 50 percent by 2050. Offering the EVO Visian ICL lens can permanently correct vision without removing corneal tissue and is reversible by a doctor for added peace of mind. It allows the patient to be more flexible in the future while also reducing the patient's reliance on glasses and contact lenses in the present.